The Purdue Pharma Company is categorized under Pharmaceutical Manufacturing Plant Construction in Stamford, CT and active since 2009.
The Purdue Pharma Company was established in 2009, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Pharmaceutical Manufacturing Plant Construction business, which does work in the B2B market, and is classified as a Pharmaceutical Manufacturing Plant Construction, under code number 236220 by the NAICS.
If you are seeking more information, feel free to contact Kenneth Hargreaves at the company’s single location by writing to 1 Stamford Forum, Stamford, Connecticut CT 06901 or by phoning No number given. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | The Purdue Pharma Company |
| Contact Person: | Kenneth Hargreaves |
| Address: | 1 Stamford Forum, Stamford, Connecticut 06901 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2009 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Pharmaceutical Manufacturing Plant Construction |
| SIC Code: | 1541 |
| NAICS Code: | 236220 |
| Share This Business: |
The Purdue Pharma Company was started in 2009 to provide professional Pharmaceutical Manufacturing Plant Construction under the SIC code 1541 and NAICS code 236220. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Kenneth Hargreaves for inquiries that concern The Purdue Pharma Company by calling the company number No number given, as your correspondence is most welcome. Additionally, the physical location of the single location of The Purdue Pharma Company can be found at the coordinates as well as the street address 1 Stamford Forum in Stamford, Connecticut 06901.
For its online presence, you may visit The Purdue Pharma Company’s website at and engage with its social media outlets through on Twitter and on Facebook.